Enterococcus faecium NCIMB 10415 administration improves the intestinal health and immunity in neonatal piglets infected by enterotoxigenic Escherichia coli K88

Table 3 Effect of E. faecium on blood routine parameters of piglets challenged with ETEC K88

Items	-ETEC		+ETEC		P-value
Items	CON	PRO	CON	PRO	PRO	ETEC	PRO×ETEC
White blood cell,10⁹/L	7.26 ± 1.20	8.80 ± 1.67	7.77 ± 0.98	8.16 ± 1.22	0.45	0.96	0.65
Lymphocytes,10⁹/L	1.46 ± 0.16^b	1.85 ± 0.19^b	2.96 ± 0.62^a	2.60 ± 0.51^ab	0.97	0.03	0.44
Neutrophils,10⁹/L	4.55 ± 0.62	4.76 ± 0.49	4.23 ± 0.77	5.23 ± 0.49	0.36	0.91	0.54
Intermediate cell, 10⁹/L	0.40 ± 0.04	0.65 ± 0.20	0.59 ± 0.13	0.56 ± 0.14	0.44	0.74	0.35
Lymphocytes, %	21.45 ± 2.51^b	25.05 ± 3.58^ab	37.24 ± 5.83^a	29.23 ± 2.60^ab	0.61	0.03	0.19
Neutrophils, %	69.40 ± 2.42	58.28 ± 6.87	54.73 ± 6.71	63.42 ± 3.75	0.82	0.39	0.08
Intermediate cell, %	6.04 ± 1.16	6.77 ± 1.31	8.03 ± 1.71	6.12 ± 0.87	0.70	0.66	0.38
Red blood cell, 10¹²/L	9.17 ± 0.37	8.77 ± 0.67	9.35 ± 0.47	9.20 ± 0.31	0.57	0.52	0.80
Haematocrit, %	78.34 ± 3.00	73.35 ± 6.70	76.69 ± 2.46	76.30 ± 1.22	0.44	0.85	0.51
Mean corpuscular volume, fL	85.56 ± 0.70	83.60 ± 3.81	82.61 ± 2.12	83.28 ± 2.21	0.79	0.50	0.58
Platelet, 10⁹/L	576.00 ± 134.95	441.50 ± 82.92	508.42 ± 109.58	636.20 ± 123.37	0.98	0.61	0.29
Thrombocytocrit, %	0.72 ± 0.24	0.45 ± 0.10	0.61 ± 0.17	0.79 ± 0.23	0.82	0.60	0.29

Data are presented as means ± SE (n = 8)
-ETEC, infusing the essential medium; +ETEC, infusing the Escherichia coli; CON, control group; PRO, Enterococcus faecium-supplemented group
^{a, b}Means within a row with different superscripts are significantly different (P < 0.05)

ISSN: 2049-1891